These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11723761)

  • 1. Epidemiology of the vasculitides.
    González-Gay MA; García-Porrúa C
    Rheum Dis Clin North Am; 2001 Nov; 27(4):729-49. PubMed ID: 11723761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects.
    González-Gay MA; García-Porrúa C
    Medicine (Baltimore); 1999 Sep; 78(5):292-308. PubMed ID: 10499071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.
    Tidman M; Olander R; Svalander C; Danielsson D
    J Intern Med; 1998 Aug; 244(2):133-41. PubMed ID: 10095799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of primary systemic vasculitides (I): ANCA-positive vasculitides].
    Guilpain P; Chanseaud Y; Tamby MC; Mahr A; Servettaz A; Guillevin L; Mouthon L
    Presse Med; 2005 Aug; 34(14):1013-22. PubMed ID: 16225257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales.
    Ormerod AS; Cook MC
    Intern Med J; 2008 Nov; 38(11):816-23. PubMed ID: 18771432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concept and epidemiology of systemic vasculitides.
    Katsuyama T; Sada KE; Makino H
    Allergol Int; 2014 Dec; 63(4):505-13. PubMed ID: 25339434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the epidemiology of systemic vasculitis.
    Cotch MF; Rao JK
    Curr Opin Rheumatol; 1996 Jan; 8(1):19-25. PubMed ID: 8867534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of the Vasculitides.
    Younger DS
    Neurol Clin; 2019 May; 37(2):201-217. PubMed ID: 30952405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification and epidemiology of the vasculitides.
    Watts RA; Scott DG
    Baillieres Clin Rheumatol; 1997 May; 11(2):191-217. PubMed ID: 9220075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is known about the epidemiology of the vasculitides?
    Watts RA; Lane S; Scott DG
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):191-207. PubMed ID: 15857791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides.
    Borgmann S; Haubitz M
    Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S79-86. PubMed ID: 15675141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of systemic vasculitis: changing incidence or definition?
    Watts RA; Carruthers DM; Scott DG
    Semin Arthritis Rheum; 1995 Aug; 25(1):28-34. PubMed ID: 8525388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation?
    Gatenby PA; Lucas RM; Engelsen O; Ponsonby AL; Clements M
    Arthritis Rheum; 2009 Oct; 61(10):1417-24. PubMed ID: 19790114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rheumatology -- Part 3. Research news concerning epidemiology, diagnosis, and therapy of primary systemic vasculitides].
    Lamprecht P; Ahmadi-Simab K; Gross WL; Hellmich B
    Med Klin (Munich); 2006 Mar; 101(3):212-25. PubMed ID: 16648979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the epidemiology, risk factors, and outcomes of systemic vasculitides.
    Berti A; Dejaco C
    Best Pract Res Clin Rheumatol; 2018 Apr; 32(2):271-294. PubMed ID: 30527432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA genes in ANCA-associated vasculitides.
    Griffith ME; Pusey CD
    Exp Clin Immunogenet; 1997; 14(3):196-205. PubMed ID: 9493788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany.
    Herlyn K; Buckert F; Gross WL; Reinhold-Keller E
    Rheumatology (Oxford); 2014 May; 53(5):882-9. PubMed ID: 24425780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Wegener granulomatosis and microscopic polyangiitis. Diagnostic and clinical results in 54 patients with long-term follow-up].
    Bolley R; Mistry-Burchardi N; Samtleben W
    Dtsch Med Wochenschr; 2000 Dec; 125(50):1519-25. PubMed ID: 11190761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.
    Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J
    Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic vasculitis presenting as a tumorlike lesion. Four case reports and an analysis of 79 reported cases.
    Kariv R; Sidi Y; Gur H
    Medicine (Baltimore); 2000 Nov; 79(6):349-59. PubMed ID: 11144033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.